HPQ Q4 Earnings Miss: Will Weak Guidance Drag the Stock Down?

HP Inc. HPQ reported fourth-quarter fiscal 2024 non-GAAP earnings of 93 cents per share, which missed the Zacks Consensus Estimate by 1.1%. The figure rose 3.3% year over year. HPQ’s earnings beat the Zacks Consensus Estimate in one of the trailing four quarters, missed twice …

Read more

Taiwan Semiconductor Ramps Up 2nm Production: Apple And AMD First In Line

Taiwan Semiconductor Manufacturing Co TSM has accelerated progress on its advanced 2-nanometer fab in Kaohsiung. The company held an equipment installation ceremony six months before schedule, reflecting its efforts to meet the global demand for advanced chips. Kaohsiung Mayor Chen Chi-mai highlighted the milestone during …

Read more

This Eastman Chemical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wells Fargo analyst Michael Sison upgraded the rating for Eastman Chemical Company EMN from Equal-Weight …

Read more

Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

PHILADELPHIA, Nov. 27, 2024 /PRNewswire/ — Carisma Therapeutics Inc. CARM (“Carisma” or the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will participate in a fireside chat at the 7th Annual Evercore …

Read more

Is Alphabet Stock a Buy Now?

Shares of Google parent Alphabet (NASDAQ: GOOGL)(NASDAQ: GOOG) were on an upswing earlier this year. The stock rose from a 52-week low of $127.90 last December to hit a high of $191.75 in July. But in August, a federal court ruled that the way the …

Read more

Do Wall Street Analysts Like Regeneron Pharmaceuticals Stock?

New York-based Regeneron Pharmaceuticals, Inc. (REGN) discovers, develops, manufactures, and commercializes medicines for treating serious medical conditions. Valued at a market cap of $81.1 billion, the company’s portfolio consists of nine marketed drugs, which are  Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. It …

Read more

A Black Friday Deal for Your Portfolio

Hello, Reader. 40% off select models. Up to 70% off clearance. Limit one coupon code per customer. We’ve been bombarded with Black Friday deals for weeks now. What used to be a one-day-only, in-store event has turned into a month-long celebration of “the best deals …

Read more

Is Teekay Tankers (TNK) a Buy as Wall Street Analysts Look Optimistic?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock’s price, but are they really important? Before we discuss the reliability of brokerage recommendations …

Read more

Microsoft's Death Cross: Tech Giant Faces A Double Blow With FTC Pressure

Microsoft Corp. MSFT, the heavyweight of Big Tech, has hit a grim milestone in technical analysis: a Death Cross. With its share price slipping below key moving averages, MSFT stock has moved into bearish territory, casting doubts on its near-term prospects. Is this just a …

Read more

Flux Power Receives Non-Compliance Letter from Nasdaq

Flux Power Holdings, Inc. FLUX, a developer of advanced lithium-ion energy storage solutions for electrification of commercial and industrial equipment, today announced that on November 20, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the …

Read more